NOVN.CH

97.19

+0.51%↑

SOON.CH

255.8

+1.07%↑

NOVN.CH

97.19

+0.51%↑

SOON.CH

255.8

+1.07%↑

NOVN.CH

97.19

+0.51%↑

SOON.CH

255.8

+1.07%↑

NOVN.CH

97.19

+0.51%↑

SOON.CH

255.8

+1.07%↑

NOVN.CH

97.19

+0.51%↑

SOON.CH

255.8

+1.07%↑

Search

Sandoz Group AG

Închisă

44.12 0.89

Rezumat

Modificarea prețului

24h

Curent

Minim

43.91

Maxim

44.14

Indicatori cheie

By Trading Economics

Venit

-299M

-149M

Vânzări

-1B

4.1B

Randament dividend

1.44

Marjă de profit

-3.671

Angajați

22,049

EBITDA

-414M

127M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

-3.67% downside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.44%

2.40%

Următoarele câștiguri

7 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

2.2B

18B

Deschiderea anterioară

43.23

Închiderea anterioară

44.12

Sandoz Group AG Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

15 apr. 2025, 09:55 UTC

Market Talk

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

17 dec. 2024, 07:45 UTC

Market Talk

Sandoz's U.S. Settlement to Cost 1.1 Swiss Francs a Share -- Market Talk

17 dec. 2024, 07:34 UTC

Market Talk

Sandoz's U.S. Settlement Shows Commitment Move Forward -- Market Talk

10 dec. 2024, 07:05 UTC

Market Talk

EU Specialty Pharma to See Product Launches But Limited Clinical Data Next Year -- Market Talk

Comparație

Modificare preț

Sandoz Group AG Așteptări

Obiectiv de preț

By TipRanks

-3.67% jos

Prognoză pe 12 luni

Medie 42.183 CHF  -3.67%

Maxim 46.5 CHF

Minim 34 CHF

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruSandoz Group AG - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

10 ratings

6

Cumpărare

4

Păstrare

0

Vânzare

Date financiare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.